We shared a couple weeks ago that CVS, walmart and other retailers were pulling Zantac from their shelves due to cancer concerns. Now Sanofi has announced that they are recalling the widely-used heartburn drug Zantac from stores in the United States and Canada in order to investigate a probable carcinogen detected in the drug.
The FDA said that it discovered a probable carcinogen called NDMA, or nitrosodimethylamine, in the drug Zantac and its generic versions. They, along with Canadian and European drug regulators, are evaluating the possible risk to millions of people who take ranitidine, the active ingredient in Zantac medications.
If you are currently taking this drug, the FDA has not recommended to stop taking it. Instead, they have advised that people who wish to discontinue their prescription should talk to their doctor or pharmacist.